128 related articles for article (PubMed ID: 19152245)
21. Pancreatic duodenal homeobox-1 (PDX1) functions as a tumor suppressor in gastric cancer.
Ma J; Chen M; Wang J; Xia HH; Zhu S; Liang Y; Gu Q; Qiao L; Dai Y; Zou B; Li Z; Zhang Y; Lan H; Wong BC
Carcinogenesis; 2008 Jul; 29(7):1327-33. PubMed ID: 18477649
[TBL] [Abstract][Full Text] [Related]
22. Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.
Chen G; Luo D
Ups J Med Sci; 2008; 113(3):297-304. PubMed ID: 18991242
[TBL] [Abstract][Full Text] [Related]
23. Clonal analysis of esophageal squamous cell carcinoma with intraepithelial components.
Tamura H; Sugihara H; Bamba M; Tani T; Hosokawa M; Kodama M; Hattori T
Pathobiology; 2001; 69(6):289-96. PubMed ID: 12324705
[TBL] [Abstract][Full Text] [Related]
24. Gastric pit dysplasia in adjacent gastric mucosa in 414 gastric cancers: prevalence and characteristics.
Shin N; Jo HJ; Kim WK; Park WY; Lee JH; Shin DH; Choi KU; Kim JY; Lee CH; Sol MY; Jeon TY; Kim DW; Huh GY; Kim GH; Lauwers GY; Park DY
Am J Surg Pathol; 2011 Jul; 35(7):1021-9. PubMed ID: 21677540
[TBL] [Abstract][Full Text] [Related]
25. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma.
Raica M; Mogoantă L; Cîmpean AM; Alexa A; Ioanovici S; Mărgăritescu C; Lazăr D; Izvernariu D
Rom J Morphol Embryol; 2008; 49(1):37-42. PubMed ID: 18273500
[TBL] [Abstract][Full Text] [Related]
27. [Effect of Helicobacter pylori on gastric epithelial cell kinetics and expression of apoptosis-related proteins in gastric carcinogenesis].
Lee KM; Lee DS; Yang JM; Ahn BM; Lee EH; Yoo JY; Kim YJ; Chung IS; Sun HS; Park DH
Korean J Gastroenterol; 2003 Jul; 42(1):12-9. PubMed ID: 14532726
[TBL] [Abstract][Full Text] [Related]
28. Spatially defined microsatellite analysis reveals extensive genetic mosaicism and clonal complexity in intestinal metaplastic glands.
Guo Y; Zhou J; Huang A; Li J; Yan M; Zhu Z; Zhao X; Gu J; Liu B; Shao Z
Int J Cancer; 2015 Jun; 136(12):2973-9. PubMed ID: 25403721
[TBL] [Abstract][Full Text] [Related]
29. Clonal analysis of isolated intestinal metaplastic glands of stomach using X linked polymorphism.
Nomura S; Kaminishi M; Sugiyama K; Oohara T; Esumi H
Gut; 1998 May; 42(5):663-8. PubMed ID: 9659161
[TBL] [Abstract][Full Text] [Related]
30. Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
Wang WC; Wu TT; Chandan VS; Lohse CM; Zhang L
Hum Pathol; 2011 Oct; 42(10):1430-7. PubMed ID: 21420715
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.
Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E
Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553
[TBL] [Abstract][Full Text] [Related]
32. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
Agoston AT; Odze RD
Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
[TBL] [Abstract][Full Text] [Related]
33. Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions.
Suzuki K; Kashimura H; Ohkawa J; Itabashi M; Watanabe T; Sawahata T; Nakahara A; Muto H; Tanaka N
J Gastroenterol Hepatol; 2000 Jul; 15(7):744-51. PubMed ID: 10937679
[TBL] [Abstract][Full Text] [Related]
34. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
[TBL] [Abstract][Full Text] [Related]
35. Analysis of p53 expression in precancerous and malignant gastric mucosa.
Romiti A; Moretti A; Vecchione A; Muraro R; Feudi ML; Rinaldi V; Mancini R; Valli C; Mozzicafreddo A; Frati L; Tomao S
Oncol Rep; 1998; 5(1):109-13. PubMed ID: 9458303
[TBL] [Abstract][Full Text] [Related]
36. [Precancerous conditions in gastric cancer (II): relationship between atrophic gastritis-intestinal metaplasia-gastric dysplasia-gastric carcinoma].
Martínez Díaz FJ; Canteras Jordana M; Ortuño Pacheco G
Rev Esp Enferm Dig; 1991 Jul; 80(1):17-21. PubMed ID: 1931240
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
38. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence.
Polkowski W; van Lanschot JJ; Ten Kate FJ; Baak JP; Tytgat GN; Obertop H; Voorn WJ; Offerhaus GJ
Surg Oncol; 1995 Jun; 4(3):163-71. PubMed ID: 7582189
[TBL] [Abstract][Full Text] [Related]
39. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
40. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis.
Mingchao ; Devereux TR; Stockton P; Sun K; Sills RC; Clayton N; Portier M; Flake G
Exp Toxicol Pathol; 2001 Sep; 53(4):237-46. PubMed ID: 11665847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
